Comments
Shares of Indoco Remedies slumped to near 3-year low on FDA concerns.
The stock fell as much 16.32 per cent to Rs 208.50, its lowest since July 30, 2014.
The US Food and Drug Administration has raised six observations in the form 483 for Goa manufacturing facility inspected last year.
FDA has accepted the company's response on four observations, but has raised concerns over the remaining two.
The observations relate to a specific product for which the company is a contract manufacturer.
Indoco stock posted biggest intraday percentage loss since June 12, 2015.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.